Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 21;17(12):e0272675. doi: 10.1371/journal.pone.0272675

Significance of two transmembrane ion gradients for human erythrocyte volume stabilization

F I Ataullakhanov 1,2,3,4,5, M V Martinov 1, Qiang Shi 6,7, V M Vitvitsky 1,*
Editor: Pramod K Yadav8
PMCID: PMC9770400  PMID: 36542609

Abstract

Functional effectiveness of erythrocytes depends on their high deformability that allows them to pass through narrow tissue capillaries. The erythrocytes can deform easily due to discoid shape provided by the stabilization of an optimal cell volume at a given cell surface area. We used mathematical simulation to study the role of transport Na/K-ATPase and transmembrane Na+ and K+ gradients in human erythrocyte volume stabilization at non-selective increase in cell membrane permeability to cations. The model included Na/K-ATPase activated by intracellular Na+, Na+ and K+ transmembrane gradients, and took into account contribution of glycolytic metabolites and adenine nucleotides to cytoplasm osmotic pressure. We found that this model provides the best stabilization of the erythrocyte volume at non-selective increase in the permeability of the cell membrane, which can be caused by an oxidation of the membrane components or mechanical stress during circulation. The volume of the erythrocyte deviates from the optimal value by no more than 10% with a change in the non-selective permeability of the cell membrane to cations from 50 to 200% of the normal value. If only one transmembrane ion gradient is present (Na+), the cell loses the ability to stabilize volume and even small changes in membrane permeability cause dramatic changes in the cell volume. Our results reveal that the presence of two oppositely directed transmembrane ion gradients is fundamentally important for robust stabilization of cellular volume in human erythrocytes.

Introduction

The main function of erythrocytes is oxygen transportation from lungs to tissues. This function is provided due to erythrocytes ability to bind big amounts of oxygen and to circulate in the bloodstream passing through narrow tissue capillaries. The ability of erythrocytes to reversibly bind oxygen is determined by a high concentration of hemoglobin in these cells (about 300 g per liter of cells [1]) and does not require energy. However, the ability of mammalian erythrocytes to circulate in the bloodstream depends on their ability to pass through narrow tissue capillaries which cross-sections frequently are smaller compared with the dimension of the erythrocytes [24]. The ability of erythrocytes to pass through narrow tissue capillaries is energy-dependent.

Erythrocytes of most mammalian species, including humans, have discoid shape but passing through the narrow capillaries they easily deform [2]. Erythrocytes with reduced deformability are removed from the bloodstream mainly in the spleen [47]. Thus, high deformability is the main criterion which determines mammalian erythrocytes usefulness and viability in an organism. The high deformability of most mammalian erythrocytes is due to elastic, but practically inextensible plasma membrane and the discoid shape of these cells [4, 8]. One should note, however, that many species in the order Artiodactyla (even-toed ungulates) have ellipsoid erythrocytes (family Camelidae), tiny spherical erythrocytes (mouse deer (family Tragulidae)), and other oddly shaped erythrocytes (family Cervidae) [914]. Conditions for effective circulation of such non-discoid erythrocytes was not well studied to our knowledge and, probably, high deformability is not so crucial for circulation of these cells [14].

Normal human erythrocytes have the shape of a biconcave disc with a diameter of 7–8 microns and a thickness of about 2 microns [15]. The discoid shape of an erythrocyte means that its cellular volume is significantly smaller than the volume of a sphere with a surface area equal to the surface area of its cell membrane. The volume of normal human erythrocytes is maintained within 55–60% of the maximum volume that a sphere with the same surface area as an erythrocyte has [16]. In other words, normally an erythrocyte has an excess surface relative to its volume. With an increase in cell volume by 1.7–1.8 times compared to normal, the erythrocyte takes the form of a sphere and, as a result, loses the ability to deform [3, 4, 16]. Since the erythrocyte membrane is inextensible, a further increase in cell volume leads to cell membrane rupture and cell lysis [4]. On the other hand, a decrease in the volume of the erythrocyte leads to an increase in the concentration of hemoglobin in the cytoplasm. As a result, the viscosity of the cytoplasm increases, and such erythrocyte becomes rigid and also loses the ability to deform and to pass through narrow tissue capillaries [3, 4, 16, 17]. Hard disk-shaped erythrocytes are unacceptable for a circulation as well as spherical cells. Therefore, the circulating erythrocytes should maintain an optimal ratio of the cell surface area to its volume. In the blood of a normal healthy donor, the cellular volume and surface area of circulating erythrocytes may vary more than two times, while the deviations of the ratio of surface area to volume for individual erythrocytes lies within ± 5% of the average value [7, 1820]. In fact, this value is stabilized within the experimental error in all circulating erythrocytes. Since cells have a number of cell volume regulating systems [21], it is reasonable to assume that the erythrocyte stabilizes its volume at a given cell membrane area so as to obtain an optimal ratio of surface area to volume.

Human erythrocyte volume depends on osmotic pressure. The erythrocyte membrane permeability to water is very high [22], and the intracellular concentration of proteins and metabolites that do not penetrate through the cell membrane is significantly higher than in blood plasma. Rough estimates show that the total difference in the concentration of osmotically active components that do not penetrate the cell membrane in erythrocytes, compared with blood plasma, is about 50 mM (50 mOsm) [23, 24]. This should lead to increased osmotic pressure inside the cells. Animal cells do not try to resist osmosis. They equalize the osmotic pressure on both sides of the cell membrane, because the cell membrane breaks easily when stretched and cannot hold a pressure exceeding 2 kPa (~1 mOsm) [25]. To compensate for the osmotic pressure caused by macromolecules and metabolites, the cell could reduce the intracellular concentration of some other substances, of which there are quite a lot both inside and outside the cell. In most cells, Na+ is used as such a substance. And it would be quite natural to have a pump that removes only Na+ from the cell to decrease an intracellular sodium concentration and to compensate a passive sodium transport to cytoplasm from the medium. To equalize the osmotic pressure between the cell and the medium it’s sufficient to reduce sodium concentration in the cell by about 50 mM compared to the medium. In reality, the concentration of Na+ in the cell is reduced to a greater extend while at the same time the cell performs seemingly meaningless work, pumping K+ into the cell in almost the same amount. Here, using a mathematical model of erythrocyte volume regulation we demonstrate the importance of the existence of two oppositely directed ion gradients between the cell and the medium.

Thus, the volume of an erythrocyte is a dynamic variable and can change easily with a change in the distribution of ions between the cell and the medium. To maintain its volume, the erythrocyte must maintain ion homeostasis. In human erythrocytes, the necessary distribution of ions between the cytoplasm and the external medium is created by an ion pump–transport Na/K-ATPase, which transfers K+ into the cell, and Na+ from the cell to the medium in a ratio of 2:3 [26, 27], thereby reducing the total content of monovalent cations in the cell compared to the medium. As a result, the osmotic pressure outside and inside the cell is equalized. It should be noted that in the stationary state, the active fluxes of Na+ and K+ through the cell membrane due to the operation of the transport Na/K-ATPase should be equal to the passive transmembrane leakage of these ions (Fig 1).

Fig 1. Interaction of transport Na/K-ATPase and glycolysis in human erythrocytes.

Fig 1

Solid and dotted purple arrows show active and passive ion fluxes through the cell membrane, respectively. Ion symbols size inside and outside the cell is proportional to the ion concentration. The red arrows show activation (+) and inhibition (-) of different metabolic processes by ions and adenylates. Green arrows show the interconversions between ATP, ADP and AMP. The additional ATPase represents the ATP consuming processes in the cell other than the active transmembrane Na+ and K+ transport.

A number of transport systems capable of normalizing the volume of cells placed in a hypotonic or hypertonic environment have been described in the literature [21]. In human erythrocytes such systems include K-Cl cotransport, Na-K-Cl cotransport, and Gardos channels [28]. However, the composition of the extracellular medium in the body is well stabilized and a change in its osmotic activity is rather an exception than a common situation. That explains why an erythrocyte is not protected against variations in osmolarity of an external medium and behaves in vitro as an ideal osmometer. While erythrocyte biochemical parameters, such as activities of glycolytic enzymes, Na/K-ATPase activity, ATP concentration, etc., slowly change during the cell aging in circulation, it looks like it does not affect dramatically the cell volume [16]. The question arises, what else can affect the volume of circulating erythrocytes, or from what influences (disorders / damage) should these cells be primarily protected by the volume stabilization systems available in them?

One of the causes for a significant change in the erythrocyte volume in the body may be a change of the permeability of the cell membrane for cations. During circulation, the erythrocyte membrane is exposed to high oxygen concentrations and a significant mechanical stress, that can both lead to a non-selective increase in its permeability to ions, that is, to the same increase in permeability for both Na+ and K+ [2936]. Experimental and theoretical studies demonstrated that this can lead to an increase in cell volume and to the lysis of erythrocytes [23, 32, 33, 37].

Despite the presence of a number of systems capable of regulating erythrocyte volume [21], the possibility of participating in the stabilization of cell volume at a non-selective increase in the permeability of the cell membrane has not been demonstrated for any of them. Moreover, possible mechanisms of erythrocyte volume regulation are discussed in the literature mainly at the descriptive level. Earlier, using mathematical modeling, we showed that the transport Na/K-ATPase can provide stabilization of the erythrocytes cell volume at a non-selective increase in the permeability of the cell membrane for cations [23, 38]. However, that mathematical models did not take into account the contribution of glycolysis metabolites and adenine nucleotides to the osmotic pressure of the cytoplasm. Here, using the updated model, which accounts for the contribution of glycolysis metabolites and adenine nucleotides to the osmotic pressure of the cytoplasm, we shown that the transport Na/K-ATPase provides the best stabilization of the erythrocyte volume at a non-selective increase in the permeability of the cell membrane. Moreover, we demonstrate that the presence of two oppositely directed transmembrane ion gradients (Na+ and K+) is crucial for the sensitivity of the cell to changes in plasma membrane permeability to cations.

Results

To study volume regulation in human erythrocytes, we constructed a mathematical model of the metabolic and transport pathways shown in Fig 1. As expected, the model shows that non-selective increase in the cell membrane permeability leads to an increase in cell volume due to an increase in the intracellular concentration of Na+ (Fig 2A and 2B). The increase in intracellular [Na+] is compensated, in part, by a decrease in intracellular [K+]. Also, the increase in the intracellular sodium concentration leads to an activation of the transport Na/K-ATPase (Fig 3A), which, in turn, leads to a compensation of the increased passive transmembrane fluxes of Na+ and K+ caused by an increase in the permeability of the cell membrane. As a result, with a twofold increase in membrane permeability, the volume of the erythrocyte increases by only 10% compared to the initial value (Fig 2A). When cell membrane permeability increases by 5 times, the volume of the erythrocyte reaches the maximum value corresponding to the spherical shape of the cell (Fig 2A), at which it completely loses the ability to deform and, consequently, to circulate in the bloodstream. Any further increase in erythrocyte volume would cause its disruption. These results are similar to data obtained using models that do not take into account the contribution of glycolysis metabolites and adenylates to the osmotic pressure of the cytoplasm [23, 38], suggesting that these metabolites do not significantly contribute to erythrocytes volume stabilization under these conditions.

Fig 2. The effect of non-selective permeability of the cell membrane for cations (g) on the erythrocyte volume and on intracellular Na+ and K+ concentrations in three different models.

Fig 2

The dependence of the relative stationary volume of the erythrocyte (A) and stationary intracellular Na+ (blue lines) and K+ (red lines) concentrations (B) on the relative non-selective permeability of the cell membrane for cations (g=GNaGNa0GKGK0). Kinetics of changes in erythrocyte volume (C) and intracellular Na+ concentration (D) after an instant 4-fold increase in the non-selective permeability of the cell membrane for cations. The kinetics of the K+ concentration is the same as for Na+, but changes occur in the direction of decreasing concentration. The black circle in the panel A indicates physiologically normal state of erythrocyte. The numbers on the curves correspond to the model versions: 1 –the version of the model with actively maintained transmembrane Na+ and K+ gradients and transport Na/K-ATPase activated by intracellular Na+; 2 –version with actively maintained transmembrane gradient only for Na+ and transport Na-ATPase activated by intracellular Na+; 3 –version with actively maintained transmembrane gradient only for Na+ and transport Na-ATPase independent of intracellular Na+. The red stripe in the panel A marks the area of maximal erythrocyte volume (V/V0 = 1.7–1.8) at which the cell takes a spherical shape.

Fig 3. The effect of non-selective permeability of the cell membrane for cations (g) on erythrocyte energy metabolism in different models.

Fig 3

(A)—The steady-state rate of ATP consumption by ion pumps; (B)—ATP concentration; (C)–Energy charge (([ATP] + 0.5[ADP])/([ATP] + [ADP] + [AMP])); (D)–Adenylate pool ([ATP] + [ADP] + [AMP]). The numbers on the curves indicate model versions as in Fig 2.

Now let us consider a model which includes only one active transmembrane ion gradient (Na+) and an ion pump which transports only Na+ out of the cell (Na-ATPase). We assume that the rate of this ATPase is proportional to the concentrations of Na+ and ATP (Eq 21). Also, we assume a passive distribution of K+ between cytoplasm and blood plasma in accordance with the transmembrane potential. In this case, steady-state intracellular [K+] is low and close to its extracellular concentration (Fig 2B). While in this model a steady-state cell volume can also be established, there is no stabilization of this volume following non-selective changes in permeability of the cell membrane for cations (Fig 2A). Even small variations of cell membrane permeability cause dramatic changes in the cell volume and intracellular ion concentrations (Fig 2A and 2B). Such lack of volume stabilization in this model system can be explained by a substantially smaller dynamic range of intracellular sodium concentration increases after a change in membrane permeability. The difference in the concentration of osmotically active components between the erythrocyte and the medium is about 50 mM, that is, about 17% of the total concentration of osmotically active components in the cell [23, 24] (Table 1). Thus, in the case of a single active transmembrane ion gradient, this gradient should be relatively small. With extracellular sodium concentration of 150 mM its intracellular concentration should be just 50 mM lower. Such a small gradient is not able to provide a significant increase in the concentration of Na+ in the cell that is necessary for the effective activation of the transport Na-ATPase when the cell membrane is damaged (Fig 2B). Furthermore, the rate of Na-ATPase in this model decreases with an increase in cell membrane permeability due to a decrease in ATP concentration caused by an increase in cell volume and dilution of adenylates (Fig 3). Interestingly, in the model with a single transmembrane ion gradient and a regulated transport Na-ATPase the cell volume stabilization is almost as bad as in a model with a single transmembrane ion gradient and an unregulated transport Na-ATPase which rate depends on [ATP] but is independent on sodium concentration (Figs 2 and 3).

Table 1. Model variables and parameters characterizing the normal physiological state of a human erythrocyte.

Variable or parameter Normal physiological value Comments References
[Cl-] 110 mmol/L cells variable, the value was calculated from the model
[Cl-]ext 150 mM parameter [23]
Em -8,4 mV variable [49]
GK0 1.24·10−2 1/h parameter, the value was calculated from the model
GNa0 1.22·10−2 1/h parameter, the value was calculated from the model
[K+] 130 mmol/L cells variable [23]
[K+]ext 5 mM parameter [23]
[Na+] 10 mmol/L cells variable [23]
[Na+]ext 145 mM parameter [23]
T 310°K parameter
V 1 L variable
W 49 mmol parameter, the value was calculated from the model
ZADP -2 parameter, the values for adenylates, G6P, and F6P charge were taken from the human metabolome database http://www.hmdb.ca
ZAMP -2 parameter, see above
ZATP -3 parameter, see above
ZG6P -2 parameter, see above
ZF6P -2 parameter, see above
Zw -0.52 parameter, the value was calculated from the model
300 mOsm parameter [23]
[ADP] 0.25 mmol/L cells variable [24]
[AMP] 0.041 mmol/L cells variable [24]
[ATP] 1.5 mmol/L cells variable [24]
[G6P] 71 μmol/L cells variable [24]
[F6P] 23 μmol/L cells variable [24]

In the case of two opposite gradients of Na+ and K+ (that is the case in most mammalian cells), the difference in the sum concentration of Na+ and K+ between the cell and the medium is the same 50 mM, but the intracellular concentration of Na+ is many times less than the concentration of Na+ in the medium. Under these conditions, when the cell membrane is damaged, the concentration of Na+ in the cell can significantly exceed its physiologically normal levels (Fig 2B) and, consequently, cause significant activation of the transport Na/K-ATPase (Fig 3A) that provides cell volume stabilization. Thus, the presence of opposite gradients of Na+ and K+ between the cytoplasm and the medium allows the cell to respond effectively to a damage of the cell membrane and stabilize the cell volume by activating the transport Na/K-ATPase. It is the large transmembrane gradient of Na+ that ensures the rapid and significant increase in its concentration in the cytoplasm when the cell membrane is damaged. And this gradient is achieved due to the presence of an oppositely directed transmembrane gradient of K+.

We also found that the transport Na/K-ATPase, which sets the ratio of transmembrane fluxes of Na+ and K+ equal to 3:2, provides the best stabilization of the erythrocyte volume at a non-selective increase in the permeability of the cell membrane, when the permeability for Na+ and K+ increases equally (Fig 4). The cell volume stabilization is much worse if the cell membrane permeability increases predominantly for one of the ions. For example, erythrocyte volume increases significantly if permeability of cell membrane for Na+ increases at unchanged permeability for K+. Conversely, erythrocyte volume decreases significantly if membrane permeability for K+ increases at unchanged permeability for Na+ (Fig 4). If both membrane permeabilities increase simultaneously, the cell volume change very little. Thus, the cell is best protected from a non-selective increase in the cell membrane permeability.

Fig 4. The dependence of the relative steady-state erythrocyte volume (V/V0) on the passive permeability of the cell membrane for K+ (GK/GK0) and Na+ (GNa/GNa0).

Fig 4

The model includes actively maintained transmembrane Na+ and K+ gradients and transport Na/K-ATPase activated by intracellular Na+ (Version 1). The black circle indicates the normal physiological state of the erythrocyte.

Interestingly, in the case of only one transmembrane ion gradient, a non-selective decrease in the permeability of the cell membrane leads to a strong decrease in cell volume (curves 2 and 3 in Fig 2A). In all models, a change in the non-selective permeability of the cell membrane leads to a more or less significant change in the cell volume (Fig 2A), leading to changes in the adenylate pool value (Fig 3D), although the amount of adenylates in the cell remains constant in the models.

The characteristic time for establishing a new steady state in the model after changing the permeability of the cell membrane is tens or even hundreds of hours due to low rates of ion fluxes through the cell membrane (Fig 2C and 2D). Moreover, in the case of two transmembrane ion gradients, the release of K+ from the cells partially compensates for the entry of Na+ into the cells which further slows down the rate of change in cell volume.

It should be noted that the stabilization of the erythrocyte volume only due to the activity of transport Na/K-ATPase is associated with significant changes in intracellular levels of Na+ and K+ (Fig 2B), that is, with a disturbance of ion homeostasis in the cell, as well as with changes in the levels of ATP and the energy charge (([ATP] + 0.5[ADP])/([ATP] + [ADP] + [AMP])) of the cell (Fig 3B and 3C).

Interestingly, two transmembrane ion gradients provide stabilization of the transmembrane potential (Fig 5A) at non-selective changes in cell membrane permeability that may be important for transmembrane transport processes. In the model the transmembrane potential is determined by concentration of chlorine ions in the erythrocyte (Eq (5)) that, in turn, is mainly determined by the content of Na+ and K+ in the cell. In the model with Na/K-ATPase the content of cations in the erythrocyte varies slightly with non-selective change in the membrane permeability because oppositely directed passive sodium and potassium fluxes largely compensate for each other and small changes in the intracellular sodium concentration are sufficient for the Na/K-ATPase to provide compensation for the passive cation fluxes. As a result, the erythrocyte volume is stabilized (Fig 2A) as well as intracellular concentrations of macromolecules and metabolites (that is described by the ratio W/V (see Table 1)), concentration of chlorine ions and transmembrane potential (Fig 5). In the model with Na-ATPase the non-selective changes in the membrane permeability associate with significant changes in the erythrocyte volume (Fig 2A) that causes significant changes in the intracellular concentrations of macromolecules and metabolites (W/V) (Fig 5B). Because the intracellular macromolecules and metabolites are mostly negatively charged, change in their concentrations causes an opposite change in concentration of chlorine ions. As a result, the intracellular concentration of chlorine ions and transmembrane potential also change significantly (Fig 5).

Fig 5.

Fig 5

The dependence of erythrocyte transmembrane potential (A) and intracellular ion concentrations (B) on the non-selective cell membrane permeability for cations (g) in different models. (A)-The numbers on the curves indicate model versions as in Fig 2; (B)-the red, blue, green, and black lines show concentrations of K+, Na+, Cl-, and total concentration of intracellular macromolecules and metabolites (W/V) respectively. Solid and dashed lines show data obtained for the model with Na/K-ATPase (model version 1), and with Na-ATPase (model version 2) respectively.

Stabilization of the erythrocyte volume in the model with two transmembrane ion gradients is not very sensitive to variation of the model parameter values such as activity of transport Na/K-ATPase or activities of glycolytic enzymes. Fig 6 demonstrates that cell volume stabilization is maintained even at twofold increase or decrease in hexokinase (HK) or transport Na/K-ATPase activity. Actually, an increase in Na/K-ATPase activity provides more possibilities for ion transport activation at increased cell membrane permeability and, thus, improves cell volume stabilization (Fig 6A). Volume stabilization gets worse at decreased Na/K-ATPase activity but still is pronounced. Hexokinase activity determines the maximal rate of glycolysis. An increase in hexokinase activity causes an increase in intracellular ATP levels and provides better support for activation of Na/K-ATPase and also improves erythrocyte volume stabilization (Fig 6B), while at decreased hexokinase activity the volume stabilization gets worse but still pronounced. Also, in the model with two transmembrane ion gradients and Na/K-ATPase the physiological volume of erythrocyte is almost independent on activities of Na/K-ATPase and hexokinase (Fig 6C and 6D). Indeed, variations in the Na/K-ATPase activity in the model are equivalent to variations in non-specific cell membrane permeability to cations that do not affect relative Na+ and K+ fluxes across cell membrane and almost do not affect ion content in cytoplasm (Fig 4). Similarly, variations in HK activity affect the maximal rate of glycolysis and activates the Na/K-ATPase due to an increase in ATP levels but do not affect ion content in cytoplasm. Contrary to that, in the case of one transmembrane ion gradient and Na-ATPase the variations in the ATPase activity as well as variations in HK activity cause asymmetric changes in Na+ and K+ fluxes and even physiological cell volume cannot be stabilized at variations of the model parameters (Fig 6C and 6D).

Fig 6. The effect of variation of transport Na/K- or Na- ATPase and hexokinase (HK) activity on erythrocyte volume stabilization.

Fig 6

Panels (A) and (B) show the dependence of the relative erythrocyte cell volume on the non-selective cell membrane permeability for cations (g) at different values of transport Na/K-ATPase activity (A) or HK activity (B) in the base version of the model (model version 1). The numbers on the curves indicate relative activity of the corresponding enzyme. Panel (C) shows the dependence of the physiological erythrocyte volume on the activity of the transport Na/K-ATPase (model version 1, curve 1) or transport Na-ATPase (model versions 2 and 3). Panel (D) shows the dependence of the physiological erythrocyte volume on HK activity in the models with Na/K-ATPase (curve 1) or with Na-ATPase (curves 2 and 3). The red stripes mark the area of maximal erythrocyte volume (V/V0 = 1.7–1.8) at which the cell takes a spherical shape. For curve 2 (panel A) and for curve 0.5 (panel B) at high g values as well as for curve 3 (panel D) at low HK activity values the steady state in glycolysis disappears.

Finally, the model with transport Na/K-ATPase and two transmembrane ion gradients predicts high sensitivity of human erythrocyte volume to changes in the content of impermeable molecules inside the cell or osmolarity of the external medium change (Fig 7) that is a well-known experimental fact demonstrating that human erythrocytes are not protected against changes in osmolarity of cytoplasm or external medium.

Fig 7. The dependence of the erythrocyte steady-state volume on the content of impermeable molecules in cytoplasm (A) and on the osmolarity of the external medium (B) in the model with two ion gradients.

Fig 7

In panel (A) parameter W (Table 1) was varied above and below its physiological value. In panel (B) parameters [Na+]ext, [K+]ext, and [Cl-]ext (Table 1) were varied above and below the physiological values simultaneously at the same proportion. The black circles indicate physiologically normal state of erythrocyte. The red stripes mark the area of maximal erythrocyte volume (V/V0 = 1.7–1.8) at which the cell takes a spherical shape.

Discussion

Our results show that the presence of two oppositely directed active transmembrane ion gradients (Na+ and K+) and the transport Na/K-ATPase activated by intracellular sodium are fundamentally important for the stabilization of cellular volume in human erythrocytes. Under these conditions, the most effective stabilization of the cell volume is provided at a non-selective increase in the permeability of the cell membrane. It seems to us that a non-selective increase in the permeability of erythrocyte membranes is the most likely damage that the cell membranes endure during circulation in the bloodstream. Based on these results, a general conclusion can be done that the presence of two oppositely directed transmembrane ion gradients (Na+ and K+) at a low intracellular concentration of the ion prevailing in the external medium (Na+) provides a greater (compared to conditions with a single gradient (Na+)) sensitivity of the cell to a damage of the cell membrane and is a fundamentally necessary condition for ensuring the stabilization of cell volume and preventing cell destruction. One can assume that such cell organization arose in the early stages of evolution and later served as the basis for the emergence of cellular electrical excitability. Also, this result casts doubt on the hypothesis that the high level of potassium in cells reflects the ionic composition of the environment in which the first cellular organisms originated [3941]. From the results presented here, it follows that in order to maintain cellular volume and preserve the integrity of cells, it would be very impractical for primary organisms to maintain an intracellular ionic composition similar to that of the external milieu.

Nevertheless, Na/K-ATPase alone is unable to provide stabilization of the erythrocyte volume in a sufficiently wide range of changes in the permeability of the cell membrane. Mathematical simulation shows that at two-fold increase in membrane permeability compared to the normal value, the cell volume increases by only ~10% (Fig 2A). However, this already goes beyond the ±5% frame in which the volume of the erythrocyte to its surface area ratio is stabilized in the body [7, 1820]. Similarly, our model predicts that an increase in cell membrane permeability of more than 5-fold leads to cell lysis, whereas literature data indicate that erythrocytes can remain in the bloodstream with an increase in the permeability of the cell membrane of more than 5–10 times compared to the normal value [4245]. The results of our previous studies show that taking into account the additional ion transport system (calcium-activated potassium channels or Gardos channels) and the metabolism of adenine nucleotides in the model makes it possible to achieve almost perfect stabilization of the erythrocyte volume with an increase in the permeability of the cell membrane up to 15 times compared to the normal value [23, 38]. In this regard, the role of Gardos channels, as well as other ion transport systems, and adenylate metabolism in stabilizing the volume of human erythrocytes should be revised using more correct models.

Methods (Mathematical model description)

Mathematical model used in this study is a system of algebraic and ordinary differential equations that describe transmembrane ion fluxes, osmotic regulation of human erythrocyte cell volume and glycolysis.

Ions and cell volume regulation

The description of ion balance and cell volume regulation is based on our earlier mathematical model of human erythrocyte volume regulation [23] and takes into account contribution of adenine nucleotides and glycolytic metabolites to osmotic balance. Eq (1) describes equivalence of osmolality in cytoplasm and in external medium (blood plasma) while the Eq (2) describes the cytoplasm electroneutrality:

ci+WV=Ω (1)
zici+zwWV=0 (2)

Here ci denotes concentration of each osmotically active cytoplasm component, which is described in the model as a variable. They are Na+, K+, and Cl-, adenylates–ATP, ADP, AMP, and glycolysis intermediates–glucose-6-phosphate (G6P) and fructose-6-phosphate (F6P). W denotes total amount of all other osmotically active components of human erythrocytes, including hemoglobin, enzymes, and metabolites, which kinetics is not described explicitly in the model. Zi denotes electrical charge of the corresponding osmotically active component. ZW denotes the average electrical charge of components not explicitly described in the model. Ω—total concentration of osmotically active components in blood plasma. V–erythrocyte volume. It is more convenient to express volume in the model as per 1013 erythrocytes that is equal to one liter rather than per one erythrocyte. Thus, under normal physiological conditions V = V0 = 1 L. In this case, the amounts of substances expressed in grams in the cells are numerically equal to their molar concentrations.

Eqs (3 and 4) describe kinetics of quantity of Na+ and K+ in erythrocytes:

d([Na+]V)dt=3UNa/KATPase+JNa (3)
d([K+]V)dt=2UNa/KATPase+JK (4)

Here UNa/K-ATPase−the rate of ATP consumption by transport Na/K-ATPase, JNa and JK are passive Na+ and K+ fluxes across cell membrane, respectively. The cell membrane permeability for Cl-anions in the erythrocyte is two orders of magnitude higher than for cations [37], therefore Eq (5) describes the equilibrium distribution of chlorine between the cytoplasm and the medium in accordance with the electric potential on the membrane:

[Cl][Cl]ext=eFEmRT (5)

Here [Cl-] and [Cl-]ext−intracellular and extracellular concentrations of chlorine ions, respectively, F–Faraday constant, Em—electrical potential on the erythrocyte cell membrane, R–universal gas constant, T—absolute temperature (310 K). Equation for the rate of Na/K-ATPase and parameter value were taken from [23]:

UNa/KATPase=ANa/KATPase[Na+][ATP] (6)

АNa/K-ATPase = 0.044 L2 / h mmol

Here АNa/K-ATPase denotes activity of the Na/K-ATPase. Hereafter, AX denotes the activity of the enzyme X.

The passive ion fluxes across the erythrocyte cell membrane are described in Goldman approximation regarding constancy of the electric field inside the cell membrane [46]:

Ji=Girer1([I]ext[I]er), (7)
r=ZiFEmRT

Here Gi−erythrocyte membrane permeability for ion I. [I] and [I]ext−concentration of ion I inside and outside of the erythrocyte, correspondingly.

Glycolysis and energy metabolism

In the model we used the simplified description of glycolysis. Only the upper part of glycolysis is explicitly described, including hexokinase, glucosephosphateisomerase, and phosphofructokinase reactions—which determine the rate of the entire glycolysis. Eqs (8 and 9) describe kinetics of quantity of G6P and F6P molecules in the erythrocyte respectively:

d([G6P]V)dt=UHKUGPI (8)
d([F6P]V)dt=UGPIUPFK (9)

Here UHK, UGPI, and UPFK denote hexokinase, glucosephosphateisomerase, and phosphofructokinase reaction rates in glycolysis, respectively. We neglect the metabolic flow in the 2,3-diphosphoglycerate shunt and assume that the rate of reactions of the lower part of glycolysis (from aldolase to lactatedehydrogenase), is equal to twice the rate of the phosphofructokinase reaction. Then the rate of ATP production in glycolysis is determined by the difference between the rates of its production in phosphoglyceratekinase (UPGK) and pyruvate kinase (UPK) reactions and consumption in hexokinase and phosphofructokinase reactions:

UHKUPFK+UPGM+UPK=UHK+3UPFK (10)

Total amount of ATP + ADP + AMP in the cells was assumed to be constant. We also assumed that rapid adenylate equilibrium exists in the cells all the time (Eq (11)).

[ATP][AMP]=[ADP]2 (11)

The energy balance in the cell can be described by the following equation:

d(qV)dt=UHK+3UPFKUNa/KATPaseUATPase (12)

Here q = 2[ATP] + [ADP], UATPase−the rate of additional ATPase reaction added to the model to balance the rates of ATP production and consumption [23, 24, 47, 48].

The presence of rapid adenylatekinase equilibrium in the cell leads to the fact that of the three variables–ATP, ADP, and AMP–only two are independent. The transition to the variables q and p = [ATP] + [ADP] + [AMP] (adenylate pool) makes it possible to exclude the rapid adenylate kinase reaction from the equations. Concentrations of ATP, ADP, and AMP at fixed values of q and p can be calculated from the following system of equations:

q=2[ATP]+[ADP]
p=[ATP]+[ADP]+[AMP] (13)
[ATP][AMP]=[ADP]2

The equations for the rates of HK, GPI, PFK, and additional ATPase reactions and parameter values were taken from [24]:

UHK=AHK[ATP]/KHK11+[ATP]/KHK1+[G6P]/KHK2 (14)

Here AHK = 12 mmol / h, KHK1 = 1 mM, КHK2 = 5.5 μM.

UGPI=AGPI([G6P][F6P]KGPI1)/KGPI21+[G6P]KGPI2+[F6P]KGPI3 (15)

Here AGPI = 360 mmol / h, КGPI1 = 3 mM, КGPI2 = 0.3 mM, КGPI3 = 0.2 mM

UPFK=APFK1.1[F6P][F6P]+KPFK1·[ATP][ATP]+KPFK2·11+[AMP]/KPFK3+2[AMP][AMP]+KPFK31+108((1+[ATP]/KPFK4)(1+[AMP]/KPFK3)(1+[F6P]/KPFK5))4 (16)

Here APFK = 380 mmol / h, КPFK1 = 0.1 mM, КPFK2 = 2 mM, КPFK3 = 0.01 mM, КPFK4 = 0.195 mM, КPFK5 = 0.37 μM.

UATPase=AATPase[ATP][ATP]+КATPase (17)

Here AATPase = 2.7 mmol / h, KATPase = 1 mM

Calculation of the model parameter values

To finalize the model, it is necessary to calculate some of its parameters–these are the normal physiological values of the intracellular concentration of chlorine ions, the permeability of the erythrocyte membrane for cations, the W value and the average charge of osmotically active components that do not penetrate the erythrocyte membrane (ZW), such as hemoglobin, enzymes and metabolites. Concentration of chlorine ions in the erythrocyte can be calculated from Eq (5), taking extracellular concentration of chlorine of 150 mM, the membrane potential of -8.4 mV and the temperature of 310 K [23, 49] (Table 1). Then, values of W and ZW are calculated from Eqs (1) and (2), using the physiological values of the variables from Table 1. According to these calculations W = 49 mmol and ZW = 0.52.

Reduction of a mathematical model to a system of ordinary differential equations

Initially the mathematical model includes five differential (3, 4, 8, 9, 12) and three algebraic (1, 2, 5) equations. If one chooses the amounts of substances in the erythrocyte as the model variables:

QK=[K+]V,QNa=[Na+]V,QCl=[Cl]V,
QG6P=[G6P]V,QF6P=[F6P]V,Qq=qV,Qp=pV (18)

and express the variables V, QCl, and Em through the remaining variables using algebraic Eqs (1, 2 and 5), then the model is transformed into a system of five ordinary differential equations, similar to (3, 4, 8, 9, 12), in respect to variables QK, QNa, QG6P, QF6P, Qq.

Investigation of the kinetic behavior of the model was performed using the CVODE software [50], and investigation of the dependence of the steady state of the model on the parameters was performed using the AUTO software [51].

Description of the cell membrane damage in the model

The main task of this work was to study the effect of non-specific damage of the cell membrane on erythrocyte volume. As it is noted in the introduction, we assume that such damage leads to a non-selective increase in the permeability of the cell membrane for all cations as:

GNa=GNa0+Δ,GK=GK0+Δ (19)

Here GNa0 and GK0 are physiological values of cell membrane permeability for Na+ and K+ respectively and Δ denotes a value of an increase in the membrane permeability for cations. Generally speaking, both an increase and a decrease in the cell membrane permeability can be described in this way. For clarity of presentation, we also introduced the parameter g corresponding to the relative permeability of the membrane for cations:

g=GNaGNa0GKPGKP0 (20)

The validity of Eq (20) follows from the fact that GNa0 ≈ GK0 (Table 1).

The mathematical model versions

Version 1. The basic version of the model describing an erythrocyte with transmembrane transport Na/K-ATPase activated by Na+, glycolysis, and constant adenylate content. The model consists of Eqs (3, 4, 8, 9 and 12) modified according to the Eq (18).

Version 2. The modified model where Na/K-ATPase was replaced with the transmembrane transport Na-ATPase (a pump that transports only Na+ from the cell to external medium) which rate is proportional to intracellular concentrations of ATP and Na+. The rate of this pump is described by the following equation:

UNaATPase2=ANaATPase2[ATP][Na+], (21)

where ANa-ATPase2 = 0.0035 L2 / h

The value of this parameter was chosen in such a way that this ATPase compensates for the passive flow of Na+ into the cell under physiological conditions.

In this version of the model the Eq (4) does not contain a term describing active potassium transmembrane transport. Thus, the rate of change in intracellular potassium concentration is determined only by a passive potassium flux across the cell membrane according to the Eq (7). Under these conditions the steady-state potassium concentration in the cells was calculated under assumption of zero passive potassium flux across the cell membrane according to the Eq (7):

[K]=[K]exteFEmRT (22)

And the steady-state sodium concentration was calculated as follows:

[Na]=140[K] (23)

Here 140 (mmol/L cells) is a sum of Na+ and K+ concentrations in erythrocytes containing Na/K-ATPase under normal conditions. This condition guarantees that the erythrocyte will have the same physiological volume and transmembrane potential in all model versions.

Version 3. A model where the Na/K-ATPase was replaced with the transmembrane transport Na-ATPase (as in Version 2) which rate depends on [ATP] but does not depend on sodium concentration. The rate of this pump is described as:

UNaATPase3=ANaATPase3[ATP] (24)

where ANa-ATPase3 = 0.46 L / h

The value of this parameter was chosen in such a way that this ATPase compensates for the passive flow of Na+ into the cell under physiological conditions. In this version of the model the intracellular potassium and sodium concentrations were calculated using the Eqs (23) and (24) the same as in Version 2.

Data Availability

All relevant data are within the paper.

Funding Statement

This work was supported in part by grant № 21-45-00012 from the Russian Science Foundation (https://rscf.ru/en/) to FIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Lang F, Foller M, editors. Erythrocytes: Physiology and pathophysiology. London: Imperial College Press; 2012. [Google Scholar]
  • 2.Reinhart WH, Huang C, Vayo M, Norwich G, Chien S, Skalak R. Folding of red blood cells in capillaries and narrow pores. Biorheology. 1991;28: 537–49. doi: 10.3233/bir-1991-28605 [DOI] [PubMed] [Google Scholar]
  • 3.Ataullakhanov FI, Vitvitskiĭ VM, Lisovskaia IL, Tuzhilova EG. [Analysis of geometric parameters and mechanical properties of erythrocytes by filtration through nuclear membrane filters. I. A mathematical model] (in Russian). Biofizika. 39: 672–80. [PubMed] [Google Scholar]
  • 4.Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112: 3939–48. doi: 10.1182/blood-2008-07-161166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chen LT, Weiss L. The role of the sinus wall in the passage of erythrocytes through the spleen. Blood. 1973;41: 529–537. doi: 10.1182/blood.v41.4.529.529 [DOI] [PubMed] [Google Scholar]
  • 6.Klausner MA, Hirsch LJ, Leblond PF, Chamberlain JK, Klemperer MR, Segel GB. Contrasting splenic mechanisms in the blood clearance of red blood cells and colloidal particles. Blood. 1975;46: 965–976. doi: 10.1182/blood.v46.6.965.965 [DOI] [PubMed] [Google Scholar]
  • 7.Pivkin I V., Peng Z, Karniadakis, Buffet PA, Dao M, Suresh S. Biomechanics of red blood cells in human spleen and consequences for physiology and disease. Proc Natl Acad Sci U S A. 2016;113: 7804–7809. doi: 10.1073/pnas.1606751113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mohandas N, Evans E. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu Rev Biophys Biomol Struct. 1994;23: 787–818. doi: 10.1146/annurev.bb.23.060194.004035 [DOI] [PubMed] [Google Scholar]
  • 9.Jain NC, Keeton KS. Morphology of camel and llama erythrocytes as viewed with the scanning electron microscope. Br Vet J. 130: 288–91. doi: 10.1016/s0007-1935(17)35895-5 [DOI] [PubMed] [Google Scholar]
  • 10.Khodadad JK, Weinstein RS. The band 3-rich membrane of llama erythrocytes: studies on cell shape and the organization of membrane proteins. J Membr Biol. 1983;72: 161–71. doi: 10.1007/BF01870583 [DOI] [PubMed] [Google Scholar]
  • 11.Fukuta K, Kudo H, Jalaludin S. Unique pits on the erythrocytes of the lesser mouse-deer, Tragulus javanicus. J Anat. 1996;189 (Pt 1: 211–3. Available: http://www.ncbi.nlm.nih.gov/pubmed/8771414 [PMC free article] [PubMed] [Google Scholar]
  • 12.Undriz E, Betke K, Lahmann H. Sickling phenomenon in deer. Nature. 1960;187: 333–4. doi: 10.1038/187333a0 [DOI] [PubMed] [Google Scholar]
  • 13.Esin A, Bergendahl LT, Savolainen V, Marsh JA, Warnecke T. The genetic basis and evolution of red blood cell sickling in deer. Nat Ecol Evol. 2018;2: 367–376. doi: 10.1038/s41559-017-0420-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Smith JE, Mohandas N, Shohet SB. Variability in erythrocyte deformability among various mammals. Am J Physiol. 1979;236: H725–30. doi: 10.1152/ajpheart.1979.236.5.H725 [DOI] [PubMed] [Google Scholar]
  • 15.Fung YC, Tsang WCO, Patitucci P. High-resolution data on the geometry of red blood cells. Biorheology. 1981;18: 369–385. doi: 10.3233/bir-1981-183-606 [DOI] [PubMed] [Google Scholar]
  • 16.Lew VL, Tiffert T. On the mechanism of human red blood cell longevity: Roles of calcium, the sodium pump, PIEZO1, and gardos channels. Front Physiol. 2017;8: 1–7. doi: 10.3389/fphys.2017.00977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Clark MR. Computation of the average shear-induced deformation of red blood cells as a function of osmolality. Blood Cells. 1989;15: 427–439. [PubMed] [Google Scholar]
  • 18.Canham PB, Burton AC. Distribution of size and shape in populations of normal human red cells. Circ Res. 1968;22: 405–422. doi: 10.1161/01.res.22.3.405 [DOI] [PubMed] [Google Scholar]
  • 19.Linderkamp O, Meiselman H. Geometric, osmotic, and membrane mechanical properties of density- separated human red cells. Blood. 1982;59: 1121–1127. doi: 10.1182/blood.v59.6.1121.1121 [DOI] [PubMed] [Google Scholar]
  • 20.Gifford SC, Frank MG, Derganc J, Gabel C, Austin RH, Yoshida T, et al. Parallel microchannel-based measurements of individual erythrocyte areas and volumes. Biophys J. 2003;84: 623–633. doi: 10.1016/S0006-3495(03)74882-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hoffmann EK, Lambert IH, Pedersen SF. Physiology of cell volume regulation in vertebrates. Physiol Rev. 2009;89: 193–277. doi: 10.1152/physrev.00037.2007 [DOI] [PubMed] [Google Scholar]
  • 22.Brahm J. Diffusional water permeability of human erythrocytes and their ghosts. J Gen Physiol. 1982;79: 791–819. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2215506&tool=pmcentrez&rendertype=abstract doi: 10.1085/jgp.79.5.791 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Martinov M V., Vitvitsky VM, Ataullakhanov FI. Volume stabilization in human erythrocytes: Combined effects of Ca2+-dependent potassium channels and adenylate metabolism. Biophys Chem. 1999;80. doi: 10.1016/s0301-4622(99)00079-4 [DOI] [PubMed] [Google Scholar]
  • 24.Martinov M V., Plotnikov AG, Vitvitsky VM, Ataullakhanov FI. Deficiencies of glycolytic enzymes as a possible cause of hemolytic anemia. Biochim Biophys Acta. 2000;1474: 75–87. doi: 10.1016/s0304-4165(99)00218-4 [DOI] [PubMed] [Google Scholar]
  • 25.Guharay F. SF. Stretch-activated single channel currents in tissue-cultured embrionic chick skeletal muscle. J Physiol. 1984;352: 685–701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sen AK, Post RL. Stoichiometry and Localization of Adenosine Triphosphate-dependent Sodium and Potassium Transport in the Erythrocyte. J Biol Chem. 1964;239: 345–352. doi: 10.1016/s0021-9258(18)51788-9 [DOI] [PubMed] [Google Scholar]
  • 27.Segel G, Feig S, Glader B, Muller A, Dutcher P, Nathan D. Energy metabolism in human erythrocytes: the role of phosphoglycerate kinase in cation transport. Blood. 1975;46: 271–278. doi: 10.1182/blood.v46.2.271.271 [DOI] [PubMed] [Google Scholar]
  • 28.Gallagher PG. Disorders of erythrocyte hydration. Blood. 2017;130: 2699–2708. doi: 10.1182/blood-2017-04-590810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Johnson RM, Gannon SA. Erythrocyte cation permeability induced by mechanical stress: A model for sickle cell cation loss. Am J Physiol—Cell Physiol. 1990;259. doi: 10.1152/ajpcell.1990.259.5.c746 [DOI] [PubMed] [Google Scholar]
  • 30.Johnson RM. Membrane stress increases cation permeability in red cells. Biophys J. 1994;67: 1876–1881. doi: 10.1016/S0006-3495(94)80669-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Jankovsky N, Caulier A, Demagny J, Guitton C, Djordjevic S, Lebon D, et al. Recent advances in the pathophysiology of PIEZO1-related hereditary xerocytosis. Am J Hematol. 2021;96: 1017–1026. doi: 10.1002/ajh.26192 [DOI] [PubMed] [Google Scholar]
  • 32.Benatti U, Morelli A, Damiani G, De Flora A. A methemoglobin-dependent and plasma-stimulated experimental model of oxidative hemolysis. Biochem Biophys Res Commun. 1982;106: 1183–1190. doi: 10.1016/0006-291x(82)91237-2 [DOI] [PubMed] [Google Scholar]
  • 33.Ataullakhanov FI, Vitvitskiĭ VM, Zhabotinskiĭ AM, Kiiatkin AB, Pichugin A V. [Metabolic changes leading to oxidative lysis of erythrocytes maintained in a normal state in vitro] (in Russian). Biokhimiia. 1986;51: 1562–70. [PubMed] [Google Scholar]
  • 34.Deuticke B, Heller KB, Haest CWM. Leak formation in human erythrocytes by the radical-forming oxidant t-butylhydroperoxide. Biochim Biophys Acta. 1986;854: 169–183. doi: 10.1016/0005-2736(86)90108-2 [DOI] [PubMed] [Google Scholar]
  • 35.Hebbel RP, Mohandas N. Reversible deformation-dependent erythrocyte cation leak. Extreme sensitivity conferred by minimal peroxidation. Biophys J. 1991;60: 712–715. doi: 10.1016/S0006-3495(91)82100-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dwight JFSJ Hendry BM. The effects of tert-butyl hydroperoxide on human erythrocyte membrane ion transport and the protective actions of antioxidants. Clin Chim Acta. 1996;249: 167–181. doi: 10.1016/0009-8981(96)06286-9 [DOI] [PubMed] [Google Scholar]
  • 37.Vitvitsky VM, Frolova E V., Martinov M V., Komarova S V., Ataullakhanov FI. Anion permeability and erythrocyte swelling. Bioelectrochemistry. 2000;52: 169–77. doi: 10.1016/s0302-4598(00)00099-4 [DOI] [PubMed] [Google Scholar]
  • 38.Ataullakhanov FI, Komarova S V., Martynov M V., Vitvitsky VM. A possible role of adenylate metabolism in human erythrocytes: 2. Adenylate metabolism is able to improve the erythrocyte volume stabilization. J Theor Biol. 1996;183: 307–316. doi: 10.1006/jtbi.1996.0222 [DOI] [PubMed] [Google Scholar]
  • 39.Dibrova D V, Galperin MY, Koonin E V, Mulkidjanian AY. Ancient Systems of Sodium/Potassium Homeostasis as Predecessors of Membrane Bioenergetics. Biochemistry (Mosc). 2015;80: 495–516. doi: 10.1134/S0006297915050016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Natochin I V, Felitsyn SB, Klimova E V, Shakhmatova EI. [K+/Na+ in the animal extracellular fluid at weathering of granitoids and problem of the origin of life] (in Russian). Zh Evol Biokhim Fiziol. 2012;48: 409–16. [PubMed] [Google Scholar]
  • 41.Danchin A, Nikel PI. Why Nature Chose Potassium. J Mol Evol. 2019;87: 271–288. doi: 10.1007/s00239-019-09915-2 [DOI] [PubMed] [Google Scholar]
  • 42.Mentzer WJ, Smith W, Goldstone J, Shohet S. Hereditary stomatocytosis: membrane and metabolism studies. Blood. 1975;46: 659–669. doi: 10.1182/blood.v46.5.659.659 [DOI] [PubMed] [Google Scholar]
  • 43.Bienzle U, Niethammer D, Kleeberg U, Ungefehr K, Kohne E, Kleihauer E. Congenital Stomatocytosis and Chronic Haemolytic Anaemia. Scand J Haematol. 1975;15: 339–346. doi: 10.1111/j.1600-0609.1975.tb01089.x [DOI] [PubMed] [Google Scholar]
  • 44.Illner H, Shires GT. Changes in sodium, potassium, and adenosine triphosphate contents of red blood cells in sepsis and septic shock. Circ Shock. 1982;9: 259–267. [PubMed] [Google Scholar]
  • 45.Orlov SN, Pokudin NI, El’-Rabi LS, Brusovanik VI, Kubatiev AA. [Transport of ions into human erythrocytes in various forms of hemolytic anemia: a correlation analysis] (in Russian). Biokhimiia. 1993;58: 866–73. [PubMed] [Google Scholar]
  • 46.Goldman DE. Potential, Impedance and Rectification in membranes. J Gen Physiol. 1943;27: 37–60. doi: 10.1085/jgp.27.1.37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Joshi A, Palsson BO. Metabolic dynamics in the human red cell. Part IV—Data prediction and some model computations. J Theor Biol. 1990;142: 69–85. doi: 10.1016/s0022-5193(05)80013-x [DOI] [PubMed] [Google Scholar]
  • 48.Ni TC, Savageau MA. Application of biochemical systems theory to metabolism in human red blood cells. Signal propagation and accuracy of representation. J Biol Chem. 1996;271: 7927–7941. doi: 10.1074/jbc.271.14.7927 [DOI] [PubMed] [Google Scholar]
  • 49.Cheng K, Haspel HC, Vallano ML, Osotimehin B, Sonenberg M. Measurement of membrane potentials (psi) of erythrocytes and white adipocytes by the accumulation of triphenylmethylphosphonium cation. J Membr Biol. 1980;56: 191–201. doi: 10.1007/BF01869476 [DOI] [PubMed] [Google Scholar]
  • 50.Cohen CD, Hindmarsh AC. CVODE, A Stiff/Nonstiff ODE Solver in C. Comput Phys. 1996;10: 138–143. [Google Scholar]
  • 51.Doedel EJ, Paffenroth RC, Champneys AR, Fairgrieve TF, Kuznetsov YA, Sandstede B, et al. AUTO 2000: Continuation and bifurcation software for ordinary differential equations (with HomCont). Tech Report, Calif Inst Technol. 2001. Available: citeulike-article-id:2673791 [Google Scholar]

Decision Letter 0

Pramod K Yadav

13 Sep 2022

PONE-D-22-20774Significance of two transmembrane ion gradients for human erythrocyte volume stabilization.PLOS ONE

Dear Dr. Vitvitsky

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

<h3>Your manuscript entitled “Significance of two transmembrane ion gradients for human erythrocyte volume stabilization."has been reviewed by two Reviewers. The Reviewers were of the opinion that the manuscript contains important information that is likely to be of interest to other investigators. However, they also identified a number of concerns that require further attention, as indicated in the reviews appended below.

Please modify the manuscript to address all of the reviewers' concerns that includes a point-by-point response to all of the issues raised in the reviews and submit the revised version via the PLOS ONE Electronic Submission site. </h3>

Please submit your revised manuscript by Oct 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Pramod K. Yadav, Ph. D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. New software must comply with the Open Source Definition.

3. Please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

4. Thank you for stating the following financial disclosure: 

"This work was supported in part by grant No 21-45-00012 from the Russian Science Foundation (https://rscf.ru/en/) to FIA."

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"This work was supported in part by grant from the Russian Science Foundation № 21-45-00012 (F.I. Ataullakhanov)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"This work was supported in part by grant No 21-45-00012 from the Russian Science Foundation (https://rscf.ru/en/) to FIA."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

7. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper by Ataullakhanov et al entitled “Significance of two transmembrane ion gradients for human erythrocyte volume stabilization” is a mathematical modeling study of the role of ionic gradients in stabilization of erythrocyte volume. Maintenance of an optimal surface-to-volume ratio is vital for the physiological function of erythrocytes as it allows them to deform easily inside the capillaries that are several-fold smaller in diameter than the cell if it were a sphere. This manuscript focuses on the benefits of having two (Na+/K+) transmembrane gradients instead of just one (Na+) and demonstrates that larger dynamic range of Na+ concentrations provided by the activity of Na+/K+-ATPase is critical for RBC volume stabilization under several-fold increases in non-specific membrane permeability to ions. The study is very interesting and has applications for other cells, such as neurons where large dynamic range of transmembrane ionic gradients is similarly physiologically vital. I have several suggestions that in my opinion will improve the manuscript and make it more accessible for wider audiences.

Major:

1. While the model describes transmembrane osmotic gradients, electrical component of ionic gradients is not discussed in the main text. The model does incorporate an algebraic equation for electroneutrality inside the cell and the dependence of passive ion fluxes on membrane potential, but it appears that erythrocyte membrane potential is a constant rather than the variable, which is a significant limitation of this study that the authors should discuss.

2. As the focus of the manuscript is on S/V stabilization, I am curious to see how robust the model is to account for natural cell-to-cell variability. For example, how well is S/V maintained when Na+/K+-ATPase surface density is changed or when intracellular “passive” osmotic pressure is varied?

Minor:

1. I don’t see much added value in the 3rd model (Na+/K+-ATPase without Na+-mediated activation). The authors should consider moving these data to supplementary materials or removing them from the manuscript.

2. Can the authors speculate on the effect of Gardos channels in this model? Shouldn’t the opening of Ca2+-sensitive K+ channels without a change in Na+ conductance worsen volume stabilization according to Fig 4?

Reviewer #2: ≤

The paper by Ataullakhanov et al. describes the important role of the Na-pump as well as the transmembrane sodium and potassium gradients for volume stabilization at increased cation permeability. The obtained results are based on mathematical modelling. In addition to former investigations, the authors took into consideration glycolytic metabolites and adenine nucleotides. The paper is well written and the results are of importance for fundamental red blood cell research.

However, the paper would improve by taking into consideration the following points:

General:

The authors state that the red blood cells change their shape when passing through narrow capillaries. Most mammalian red blood cells can transform from discocytes to echinocytes or stomatocytes. However, the red cells from camels are ellipsoid and do not change the shape. This should be added at least in parenthesis.

In the text (Results) a permeability increase of 5 times is mentioned, whereas in Fig. 2 a 4-fold increase is given in the legend.

It is mentioned that a sodium and potassium gradient is existing in most mammalian cells. Investigating red blood cells, it should be mentioned that in most cases this is based on the sodium pump. However, dog and cat red cells do not have a sodium pump but have also such gradients. It is due to the existence of a Ca/Na exchanger (absent in other mammalian red blood cells), which produces based on the calcium pump a Na gradient and based on this Na gradient a Na,K,2Cl cotransporter produces a K gradient.

I would suggest to take out the statement given in lines 295 – 299. It would need more basic research on membrane ion transport processes.

Furthermore, the authors take into consideration the Gardos channel as an additional ion transport system. However, there are much more cation transport systems in the red blood cell membrane. I would like to have a paragraph mentioning these systems and discussing a possible role in the effect investigated in the present paper. At least the authors should say that it is planned to take such ion transport systems into account.

Minor points:

Throughout the paper “erythrocyte” or “red blood cells” should be used. In addition, non-selective should be written with – throughout the paper. Define A in mathematical equations.

Line 28: the role …

Line 105: Instead: … reduced significantly more. Better: … reduced to a greater extend.

Line 122: … why an erythrocyte …

Line 124: Delete space in Na/ K-ATPase

Line 127: … of an erythrocyte.

Line 131: Instead of disturbance – change of the permeability

Line 132: Instead of undergoes – underlie significant mechanical stress, ….

Lines 156, 348, 355 – comma before respectively.

Lines 202, 234, 240 - Figs.

Line 287: Instead of … damage to the cell membrane of these cells - … effect on the membrane of these cells ….

Line 335: Comma before which

Line 357 (and further on, e.g. 438): There is no °K – only K.

Line 418: 5.5

Line 429: ATP not Russian ATF

Table: 3 times parameter in Russian.

References: Instead of brackets it should be stated (in Russian) – ref 3, 26, 33, 38.

What means n.d. in ref. 3?

Some references (titles) are written with capital letters (20, 32, 34, 36, 39). Most references, however with small letters.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Prof. Dr. Ingolf Bernhardt

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 21;17(12):e0272675. doi: 10.1371/journal.pone.0272675.r002

Author response to Decision Letter 0


8 Nov 2022

We are grateful to the Reviewers for their valuable comments and suggestions which, to our opinion, caused a significant improvement of the manuscript. Below are our responses to the Reviewer’s comments.

Reviewer #1

The paper by Ataullakhanov et al entitled “Significance of two transmembrane ion gradients for human erythrocyte volume stabilization” is a mathematical modeling study of the role of ionic gradients in stabilization of erythrocyte volume. Maintenance of an optimal surface-to-volume ratio is vital for the physiological function of erythrocytes as it allows them to deform easily inside the capillaries that are several-fold smaller in diameter than the cell if it were a sphere. This manuscript focuses on the benefits of having two (Na+/K+) transmembrane gradients instead of just one (Na+) and demonstrates that larger dynamic range of Na+ concentrations provided by the activity of Na+/K+-ATPase is critical for RBC volume stabilization under several-fold increases in non-specific membrane permeability to ions. The study is very interesting and has applications for other cells, such as neurons where large dynamic range of transmembrane ionic gradients is similarly physiologically vital. I have several suggestions that in my opinion will improve the manuscript and make it more accessible for wider audiences.

Major:

1. While the model describes transmembrane osmotic gradients, electrical component of ionic gradients is not discussed in the main text. The model does incorporate an algebraic equation for electroneutrality inside the cell and the dependence of passive ion fluxes on membrane potential, but it appears that erythrocyte membrane potential is a constant rather than the variable, which is a significant limitation of this study that the authors should discuss.

The erythrocyte transmembrane potential is not a constant in the model. It is associated with the distribution of Cl- ions across the cell membrane because the cell membrane permeability for Cl-anions in the erythrocyte is two orders of magnitude higher than for cations [1]. In the presence of two transmembrane ion gradients an increase in cell membrane permeability to cations causes a redistribution of Na+ and K+ ions across the cell membrane while the distribution of Cl- anions and transmembrane potential almost do not change. However, in the case of only one transmembrane ion gradient the transmembrane potential changes dramatically with the change in the cell membrane permeability to cations. We added corresponding explanations and figure illustrating the behavior of transmembrane potential to the manuscript (lines 273-290, Fig. 5).

2. As the focus of the manuscript is on S/V stabilization, I am curious to see how robust the model is to account for natural cell-to-cell variability. For example, how well is S/V maintained when Na+/K+-ATPase surface density is changed or when intracellular “passive” osmotic pressure is varied?

Variation of most model parameters do not affect stabilization of erythrocyte cell volume significantly. We added a new paragraph (lines 291-311) and a figure (Fig. 6) that show that the cell volume is stabilized even if Na/K-ATPase or hexokinase activity increase or decrease two times compared with the normal value. However, the erythrocyte cell volume is not stabilized and changes proportional to a content of impermeable molecules in the cell or proportional to osmolarity of the medium that confirms the reputation of the human erythrocyte as an ideal osmometer (lines 312-316, Fig. 7).

Minor:

1. I don’t see much added value in the 3rd model (Na+/K+-ATPase without Na+-mediated activation). The authors should consider moving these data to supplementary materials or removing them from the manuscript.

The main role of this model is to demonstrate that the volume stabilization in the case of one transmembrane ion gradient with the regulated transport Na-ATPase is almost as bad as with unregulated Na-ATPase. We added this explanation to the text (lines 200-204) and prefer to keep the 3-d model version in the main manuscript.

2. Can the authors speculate on the effect of Gardos channels in this model? Shouldn’t the opening of Ca2+-sensitive K+ channels without a change in Na+ conductance worsens volume stabilization according to Fig 4?

We studied a possible effect of Gardos channels on human erythrocyte volume stabilization in the paper published in the Biophysical Chemistry, 80, 199-215, 1999 [2]. Of course, opening of Gardos channels along can worsen the stabilization of human erythrocytes cell volume. And it happens probably in case of pathology named hereditary xerocytosis [3]. However, it was shown that in case of increase in non-selective cell membrane permeability the functioning of the Gardos channels can significantly improve the erythrocyte cell volume stabilization [2] (see lines 380-384 in Discussion).

References

1. Vitvitsky VM, Frolova E V, Martinov M V, Komarova S V, Ataullakhanov FI. Anion permeability and erythrocyte swelling. Bioelectrochemistry 2000;52:169–77.

2. Martinov M V., Vitvitsky VM, Ataullakhanov FI. Volume stabilization in human erythrocytes: Combined effects of Ca2+-dependent potassium channels and adenylate metabolism. Biophys Chem 1999; 80:199–215.

3. Gallagher P.G. Disorders of erythrocyte hydration. Blood 130, 2699-2708, 2017.

Reviewer #2

The paper by Ataullakhanov et al. describes the important role of the Na-pump as well as the transmembrane sodium and potassium gradients for volume stabilization at increased cation permeability. The obtained results are based on mathematical modelling. In addition to former investigations, the authors took into consideration glycolytic metabolites and adenine nucleotides. The paper is well written and the results are of importance for fundamental red blood cell research.

However, the paper would improve by taking into consideration the following points:

General:

The authors state that the red blood cells change their shape when passing through narrow capillaries. Most mammalian red blood cells can transform from discocytes to echinocytes or stomatocytes. However, the red cells from camels are ellipsoid and do not change the shape. This should be added at least in parenthesis.

Thank you for this correction. We mentioned this information in the Introduction (lines 57-67) with corresponding references.

In the text (Results) a permeability increase of 5 times is mentioned, whereas in Fig. 2 a 4-fold increase is given in the legend.

We note in the text (lines 172-175) that at 5-fold increase in cell membrane permeability erythrocyte gets a spherical shape and any further increase in the permeability causes the cell damage. In the Fig. 2 we demonstrate a kinetics of cell volume and intracellular [Na+] at cell membrane permeability increase (4-fold) that does not cause the cell destruction yet. In the revised version of the manuscript, we indicated limits of erythrocyte volume increase in Fig 2A and in new figures (Fig 6, and Fig 7).

It is mentioned that a sodium and potassium gradient is existing in most mammalian cells. Investigating red blood cells, it should be mentioned that in most cases this is based on the sodium pump. However, dog and cat red cells do not have a sodium pump but have also such gradients. It is due to the existence of a Ca/Na exchanger (absent in other mammalian red blood cells), which produces based on the calcium pump a Na gradient and based on this Na gradient a Na, K,2Cl cotransporter produces a K gradient.

We know about an “unusual” mechanism of the maintenance of transmembrane sodium ion gradient in dog and cat erythrocytes. We think that it would be very interesting to investigate how effective this mechanism is in maintaining a constant surface area to volume ratio. But this mechanism is not well studied to our knowledge. Also, it was shown recently, that at least in some dog breeds animals with normal transport Na/K-ATPase in erythrocytes exist, that maintain Na+ and K+ transmembrane gradients similar to other species [1-3]. This topic is beyond of aims of our study and we would not like to discuss it here.

I would suggest to take out the statement given in lines 295 – 299. It would need more basic research on membrane ion transport processes.

To our knowledge, there are no good rational hypotheses regarding necessity of two opposite transmembrane ion gradients with high intracellular concentration of K+ ions in majority of cells. We do not pretend to present a complete explanation of that phenomenon but, in our opinion, we offer a reasonable assumption about it and would like to mention it in the text.

Furthermore, the authors take into consideration the Gardos channel as an additional ion transport system. However, there are much more cation transport systems in the red blood cell membrane. I would like to have a paragraph mentioning these systems and discussing a possible role in the effect investigated in the present paper. At least the authors should say that it is planned to take such ion transport systems into account.

Thank you for this comment. We mentioned the cation transport systems presented in human erythrocytes in the Introduction (lines 120-122). Also, we mentioned in the Discussion section (line 384-386) the necessity to investigate a contribution of other ion transport system in erythrocyte volume stabilization.

Minor points:

Throughout the paper “erythrocyte” or “red blood cells” should be used (Corrected). In addition, non-selective should be written with – throughout the paper (Corrected). Define A in mathematical equations – A description of parameter A was added to the text (lines 435, 436).

Line 28: the role …- Corrected

Line 105: Instead: … reduced significantly more. Better: … reduced to a greater extend. - Corrected

Line 122: … why an erythrocyte …- Corrected

Line 124: Delete space in Na/ K-ATPase - Corrected

Line 127: … of an erythrocyte. - Corrected

Line 131: Instead of disturbance – change of the permeability - Corrected

Line 132: Instead of undergoes – underlie significant mechanical stress, ….-Corrected

Lines 156, 348, 355 – comma before respectively.- Corrected

Lines 202, 234, 240 - Figs. - Corrected

Line 287: Instead of … damage to the cell membrane of these cells - … effect on the membrane of these cells ….- We corrected the phrase in a different way (Line 350).

Line 335: Comma before which - Corrected

Line 357 (and further on, e.g. 438): There is no °K – only K. - Corrected

Line 418: 5.5 - Corrected

Line 429: ATP not Russian ATF (actually, it was line 492) - Corrected

Table: 3 times parameter in Russian. - Corrected

References: Instead of brackets it should be stated (in Russian) – ref 3, 26, 33, 38.- the brackets were added by the reference manager software (Mendeley). We stated that the referred papers are in Russian.

What means n.d. in ref. 3?

Some references (titles) are written with capital letters (20, 32, 34, 36, 39). Most references, however with small letters. – All issues regarding the References were corrected.

References

1. Maede Y., Inaba M., Taniguchi N. Increase of Na-K-ATPase activity, glutamate, and aspartate uptake in dog erythrocytes associated with hereditary high accumulation of GSH, glutamate, glutamine, and aspartate. Blood 61, 493-499, 1983.

2. Fujise H., Higa K., Nakayama T., Wada K., Ochiai H., Tanabe Y. Incidence of dog possessing red blood cell with high K in Japan and East Asia. J. Vet. Med. Sci. 59, 497-497, 1997.

3. Conrado F.O., Oliveira S.T., Lacerda L.A., Silva M.O.D., Hlavac N., Gonzalez F.H.D. Clinicopathologic and electrocardiographic features of Akita dogs with high and low erythrocyte potassium phenotypes. Vet. Clin. Pathol. 43, 50–54, 2014.

Sincerely yours

Victor M. Vitvitsky, D.Sc.

Center for Theoretical Problems of Physico-Chemical Pharmacology

Russian Academy of Sciences

Moscow 109029, Russia

E-mail: victor_vitvitsky@yahoo.com

Attachment

Submitted filename: RespToRev.docx

Decision Letter 1

Pramod K Yadav

6 Dec 2022

Significance of two transmembrane ion gradients for human erythrocyte volume stabilization.

PONE-D-22-20774R1

Dear Dr. Vitvitsky,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Pramod K. Yadav, Ph. D.

Academic Editor

PLOS ONE

Additional Editor Comments:

Suggestions to the authors by Dr. Ingolf Bernhardt need to be incorporated

The manuscript improved significantly after revision. However, there are some points to take into consideration.

Please go through the manuscript again and change Na+ ions and sodium ions in Na+ only. It should be identical everywhere (Na+ is an ion, you do not need to write ion. Alternatively Na ions). In some places it is correct!

Line 15: Do not start a sentence with „And …..“.

Line 270: version 2 (small v), cp. other places

Line 297: Point is missing after Fig

Line 394: Why here capital letters (see below other headlines)

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: Suggestions to the authors

The manuscript improved significantly after revision. However, there are some points to take into consideration.

Please go through the manuscript again and change Na+ ions and sodium ions in Na+ only. It should be identical everywhere (Na+ is an ion, you do not need to write ion. Alternatively Na ions). In some places it is correct!

Line 15: Do not start a sentence with „And …..“.

Line 270: version 2 (small v), cp. other places

Line 297: Point is missing after Fig

Line 394: Why here capital letters (see below other headlines)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Prof. Dr. Ingolf Bernhardt

**********

Acceptance letter

Pramod K Yadav

12 Dec 2022

PONE-D-22-20774R1

Significance of two transmembrane ion gradients for human erythrocyte volume stabilization.

Dear Dr. Vitvitsky:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Pramod K. Yadav

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: RespToRev.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES